Clinical Trials Browser

Phase 2 × NIH × exatecan × Clear all

NCT00005091 2013-07-10

DX-8951f in Treating Previously Untreated Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms